Filter
10534
Filtered Results: 10534
Text search:
care
group
Featured
Recommendations
921
New Publications
2750
Language
Document type
No document type
6074
Studies & Reports
1686
Guidelines
1276
Manuals
551
Strategic & Response Plan
340
Training Material
212
Fact sheets
206
Situation Updates
105
Resource Platforms
31
Brochures
23
Infographics
23
Online Courses
5
Dashboards/Maps
1
App
1
Countries / Regions
India
500
Global
391
Kenya
306
South Africa
235
Ethiopia
225
Nepal
202
Sierra Leone
198
Nigeria
191
Uganda
191
Liberia
180
Western and Central Europe
178
Myanmar / Burma
178
Bangladesh
161
Malawi
150
Syria
145
Zambia
144
Latin America and the Carribbean
142
Tanzania
136
Rwanda
133
Africa
128
Ukraine
124
Ghana
120
Congo, Democratic Republic of
96
Philippines
92
Indonesia
81
South Sudan
78
Namibia
77
Zimbabwe
71
Lesotho
69
Eastern Europe
69
South–East Asia Region
65
Russia
63
Cambodia
62
Germany
62
Brazil
61
Mozambique
59
Haiti
59
Senegal
58
Asia
58
Guinea
51
Yemen
48
Venezuela
47
Burkina Faso
45
Middle East and North Africa
43
East and Southern Africa
43
Botswana
42
West and Central Africa
40
Eastern Europe and Central Asia
38
Cameroon
34
Colombia
33
Eswatini/ Swaziland
31
Afghanistan
29
Lebanon
29
Pakistan
27
Sudan
26
Jordan
25
Thailand
24
Central African Republic
23
Madagascar
23
Benin
21
Vietnam
20
Somalia
20
USA
19
Tajikistan
18
Western Pacific Region
17
Mali
17
Iraq
17
Peru
16
China
15
Paraguay
15
Turkey
14
Chile
14
Albania
14
Sri Lanka
14
Laos
13
Moldova
13
Angola
13
Argentina
12
Georgia
12
Ecuador
12
Côte d’Ivoire / Ivory Coast
11
North Macedonia
10
Papua New Guinea
10
Spain
9
Palestine
9
Mexico
8
Iran
8
Burundi
8
Guinea-Bissau
8
Southern Africa
8
Libya
8
Jamaica
7
Chad
7
Kazakhstan
6
Kyrgyzstan
6
Niger
6
Armenia
6
United Kingdom
6
Portugal
6
Bolivia
6
Egypt
6
Greece
6
Timor Leste/ East Timor
5
Serbia
5
Malaysia
5
Hungary
5
North America
5
Romania
5
Poland
5
Gambia
4
Togo
4
Canada
4
Estonia
4
Turkmenistan
4
Japan
4
Bhutan
4
Switzerland
3
El Salvador
3
Singapore
3
Morocco
3
Saudi Arabia
3
Mauritius
3
Tunisia
3
Belarus
3
Guatemala
3
North Korea
2
Fiji
2
Uzbekistan
2
Mongolia
2
Qatar
2
Bulgaria
2
Italy
2
Croatia
2
Lithuania
2
Ireland
2
Gabon
2
Belgium
2
France
2
Azerbaijan
2
Australia
1
Congo-Brazzaville
1
Vanuatu
1
Mauritania
1
Dominican Republic
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Nicaragua
1
Djibouti
1
Slovakia
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3988
Clinical Guidelines
764
Women & Child Health
595
Public Health
536
Key Resources
414
Capacity Building
243
Pharmacy & Technologies
85
Annual Report MEDBOX
3
Toolboxes
COVID-19
960
Mental Health
915
HIV
810
TB
519
Disability
461
Conflict
329
Caregiver
320
Ebola
291
Planetary Health
282
Rapid Response
279
AMR
270
Refugee
225
NTDs
206
NCDs
192
Pharmacy
166
Global Health Education
155
Natural Hazards
130
Health Financing Toolbox
91
Social Ethics
71
Cholera
62
Specific Hazards
57
Zika
53
Polio
39
Typhoon
6
South Sudan
3
Health Financing
2
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
A sanitary inspection is a simple, on-site evaluation (traditionally using a checklist) to help identify and support the management of priority risk factors that may lead to contamination of a drinking-water supply. Sanitary inspections are a well-established and widely-applied practice. They can su...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
